Cart
sales@molnova.com
Home -
Products -
Apoptosis -
Serine/threonin kinase -
CRT0066101 dihydrochloride(956121-30-5 free base)
CRT0066101 dihydrochloride(956121-30-5 free base)
CAS No. 2308510-39-4
CRT0066101 dihydrochloride(956121-30-5 free base)( —— )
Catalog No. M24052 CAS No. 2308510-39-4
CRT0066101 dihydrochloride is an inhibitor of PKD.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 120 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 350 | In Stock |
|
| 100MG | 529 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCRT0066101 dihydrochloride(956121-30-5 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionCRT0066101 dihydrochloride is an inhibitor of PKD.
-
DescriptionCRT0066101 dihydrochloride is an inhibitor of PKD.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetSerine/threonin kinase
-
RecptorPKD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2308510-39-4
-
Formula Weight415.74
-
Molecular FormulaC18H21N4OCl3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESOC(C=CC(Cl)=C1)=C1C2=NC(C=CC=C3)=C3C(NC[C@H](N)CC)=N2.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Borges S , EA Perez, EA Thompson, et al. Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101.[J]. Molecular Cancer Therapeutics, 2015, 14(6).
molnova catalog
related products
-
TAO Kinase inhibitor...
TAO Kinase inhibitor 2 is a TAO kinase inhibitor with an IC50 of 50-500 nM. TAO Kinase inhibitor 2 inhibits KIAA1361 and JIK with IC50s of 50-500 nM.
-
HA-1004
HA-1004 is a inhibitor of PKG, PKA, PKC and MLC.
-
PCSK9-IN-10
PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 μM.
